Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PRIMARY HYPERPARATHYROIDISM, . Treffer: 25
2023
Appelman-Dijkstra, NM; Pilz, S
Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy.
J Clin Endocrinol Metab. 2023; 108(6):1505-1513
Doi: 10.1210/clinem/dgac734
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2022
Bollerslev, J; Rejnmark, L; Zahn, A; Heck, A; Appelman-Dijkstra, NM; Cardoso, L; Hannan, FM; Cetani, F; Sikjær, T; Formenti, AM; Björnsdottir, S; Schalin-Jantti, C; Belaya, Z; Gibb, FW; Lapauw, B; Amrein, K; Wicke, C; Grasemann, C; Krebs, M; Ryhänen, EM; Makay, O; Minisola, S; Gaujoux, S; Bertocchio, JP; Hassan-Smith, ZK; Linglart, A; Winter, EM; Kollmann, M; Zmierczak, HG; Tsourdi, E; Pilz, S; Siggelkow, H; Gittoes, NJ; Marcocci, C; Kamenicky, P, , 2021, PARAT, Working, Group
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.
Eur J Endocrinol. 2022; 186(2):R33-R63
Doi: 10.1530/EJE-21-1044
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Nazerani Hooshmand, T; Pernthaler, B; Szurian, K; Pau, M; Aigner, RM
18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor Syndrome.
Clin Nucl Med. 2021; 46(6):497-498
Doi: 10.1097/RLU.0000000000003625
Web of Science
PubMed
FullText
FullText_MUG
2019
Amrein, K; Dobnig, H
Primary hyperparathyroidism. Three interesting case reports and innovations in diagnosis and therapy
AUST J CLIN ENDOCR M. 2019; 12(2): 50-54.
Doi: 10.1007/s41969-019-0063-x
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Bollerslev, J; Schalin-Jantti, C; Rejnmark, L; Siggelkow, H; Morreau, H; Thakker, RV; Sitges-Serra, A; Cetani, F; Marcocci, C; PARAT Workshop Group
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.
EUR J ENDOCRINOL. 2019; 181(3): P1-P19.
Doi: 10.1530/EJE-19-0316
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Beheshti, M; Hehenwarter, L; Paymani, Z; Rendl, G; Imamovic, L; Rettenbacher, R; Tsybrovskyy, O; Langsteger, W; Pirich, C
18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.
Eur J Nucl Med Mol Imaging. 2018; 45(10): 1762-1771.
Doi: 10.1007/s00259-018-3980-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pilz, S; Trummer, C; Verheyen, N; Schwetz, V; Pandis, M; Aberer, F; Grübler, MR; Meinitzer, A; Bachmann, A; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; März, W; Obermayer-Pietsch, B; Tomaschitz, A
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Horm Metab Res. 2018; 50(5):375-382
Doi: 10.1055/a-0604-3249
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Vlot, MC; den Heijer, M; de Jongh, RT; Vervloet, MG; Lems, WF; de Jonge, R; Obermayer-Pietsch, B; Heijboer, AC
Clinical utility of bone markers in various diseases.
Bone. 2018; 114(7):215-225
Doi: 10.1016/j.bone.2018.06.011
Web of Science
PubMed
FullText
FullText_MUG
2017
Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799
Doi: 10.1371/journal.pone.0173799
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Grübler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; März, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A
Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Bone. 2017; 105(5):212-217
Doi: 10.1016/j.bone.2017.08.030
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Meinitzer, A; Grübler, MR; Ablasser, K; Kolesnik, E; Fahrleitner-Pammer, A; Belyavskiy, E; Trummer, C; Schwetz, V; Pieske-Kraigher, E; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; Brussee, H; Lewinski, DV; März, W; Pieske, B; Pilz, S; Tomaschitz, A
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Clin Chem Lab Med. 2017; 55(7):1034-1042
Doi: 10.1515/cclm-2016-1159
Web of Science
PubMed
FullText
FullText_MUG
Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180
Doi: 10.1111/jch.13064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56
Doi: 10.1097/HJH.0000000000000927
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86
Doi: 10.1097/HJH.0000000000001004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11
Doi: 10.1097/MAJ.0000000000000419
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Wetzel, J; Martensen, J; Belyavskiy, E; Schmidt, A; Colantonio, C; Catena, C; Gaksch, M; Grübler, MR; Kraigher-Krainer, E; Pieske, B; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A
9B.05: ASSOCIATION OF PLASMA PARATHYROID HORMONE WITH NIGHTTIME BLOOD PRESSURE IN PRIMARY HYPERPARATHYROIDISM-THE "EPLERENONE IN PRIMARY HYPERPARATHYROIDISM" TRIAL.
J Hypertens. . 2015; 33 Suppl 1(10):e121-e121.
Doi: 10.1097/01.hjh.0000467677.24307.ad
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
2013
Kirsch, AH; Smaczny, N; Riegelbauer, V; Sedej, S; Hofmeister, A; Stojakovic, T; Goessler, W; Brodmann, M; Pilger, E; Rosenkranz, AR; Eller, K; Eller, P
Regulatory T cells improve nephrocalcinosis but not dystrophic cardiac calcinosis in DBA/2 mice.
Am J Pathol. 2013; 183(2):382-390
Doi: 10.1016/j.ajpath.2013.04.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Pilz, S; Eller, K; Kienreich, K; Fahrleitner-Pammer, A; Pieske, B; Ritz, E; Tomaschitz, A
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Expert Opin Pharmacother. 2013; 14(6):793-806
Doi: 10.1517/14656566.2013.777041
Web of Science
PubMed
FullText
FullText_MUG
2012
Osto, E; Fallo, F; Pelizzo, MR; Maddalozzo, A; Sorgato, N; Corbetti, F; Montisci, R; Famoso, G; Bellu, R; Lüscher, TF; Iliceto, S; Tona, F
Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.
Circulation. 2012; 126(9):1031-9
Doi: 10.1161/CIRCULATIONAHA.111.081307
Web of Science
PubMed
FullText
FullText_MUG
Tomaschitz, A; Fahrleitner-Pammer, A; Pieske, B; Verheyen, N; Amrein, K; Ritz, E; Kienreich, K; Horina, JH; Schmidt, A; Kraigher-Krainer, E; Colantonio, C; Meinitzer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
BMC Endocr Disord. 2012; 12(12):19-19
Doi: 10.1186/1472-6823-12-19
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tomaschitz, A; Ritz, E; Pieske, B; Fahrleitner-Pammer, A; Kienreich, K; Horina, JH; Drechsler, C; März, W; Ofner, M; Pieber, TR; Pilz, S
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Cardiovasc Res. 2012; 94(1):10-19
Doi: 10.1093/cvr/cvs092
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1998
Kotzmann, H; Köller, M; Abela, C; Clodi, M; Riedl, M; Graninger, W; Niederle, B; Luger, A
Effects of parathyroid hormone and serum calcium on the phenotype and function of mononuclear cells in patients with primary hyperparathyroidism.
Eur J Clin Invest. 1998; 28(5): 353-358.
Doi: 10.1046/j.1365-2362.1998.00283.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1997
Dobnig, H; Turner, RT
The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.
Endocrinology. 1997; 138(11):4607-4612
Doi: 10.1210/endo.138.11.5505
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1994
Schafhalter-Zoppoth, I; Eber, B; Lax, S; Wolf, G; Grisold, M; Aichbichler, B; Dobnig, H; Klein, W
Coronary heart disease as the initial manifestation of primary hyperparathyroidism].
Wien Klin Wochenschr. 1994; 106(16):527-530
(- Case Report)
Web of Science
PubMed
1991
Schmid, KW; Hittmair, A; Ladurner, D; Sandbichler, P; Gasser, R; Tötsch, M
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Virchows Arch A Pathol Anat Histopathol. 1991; 418(4):295-299
Doi: 10.1007/BF01600157
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar